![Manuela Cazzanti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manuela Cazzanti
Plus aucun poste en cours
Profil
Manuela Cazzanti is the founder of AgomAb Therapeutics NV, which was founded in 2017.
Anciens postes connus de Manuela Cazzanti
Sociétés | Poste | Fin |
---|---|---|
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |